Roche to buy COVID test maker GenMark Diagnostics for $1.8 bn
Swiss pharma giant Roche said Monday it would pay $1.8 billion (1.5 billion euros) to buy US firm GenMark Diagnostics and thus broaden its rapid test portfolio, including for COVID-19.
Mar 15, 2021
0
4